Industry: Chemical & Material
Published Date: 2025-03-26
Pages: 90 Pages
Report ld: 4194454
Request Sample
Customized Report
Dehydroepiandrosterone (DHEA) Market Size(US$)

CAGR 2025-2031
7.1%
Market Size,2031
USD 76.7
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Dehydroepiandrosterone (DHEA) was valued at US$ 49 million in the year 2024 and is projected to reach a revised size of US$ 76.7 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Dehydroepiandrosterone (DHEA), also known as androstenolone, is an endogenous steroid hormone precursor. It is one of the most abundant circulating steroids in humans. DHEA is produced in the adrenal glands, the gonads, and the brain. It functions as a metabolic intermediate in the biosynthesis of the androgen and estrogen sex steroids both in the gonads and in various other tissues. However, DHEA also has a variety of potential biological effects in its own right, binding to an array of nuclear and cell surface receptors, and acting as a neurosteroid and modulator of neurotrophic factor receptors.
Research institutions and pharmaceutical companies are exploring prasterone's potential beyond its current uses, including neuroprotection and metabolic modulation, potentially broadening its market scope. In developed regions like the U.S. and Europe, prasterone is increasingly seen as part of the growing hormone replacement therapy market, driven by an aging population seeking to address not only physical but also sexual and cognitive health declines. As DHEA levels naturally decrease after age 30—particularly rapidly in women—the need for hormonal balance interventions has grown, making prasterone-based therapies more appealing. Additionally, a broader wellness trend focusing on holistic health and quality of life improvements has positioned prasterone as a non-traditional yet scientifically backed option. Significant investments in research by both academia and industry have accelerated the understanding of prasterone's multifaceted benefits, supporting its development as a safer alternative for hormone replacement. Simultaneously, the facial mask market is expanding due to increased skincare awareness among younger generations and the influence of strong skincare cultures in South Korea, Japan, and China. The rise of online sales channels, live streaming, and influencer marketing has amplified brand reach, especially among younger, trend-driven consumers. Men are increasingly embracing skincare, expanding the consumer base, particularly in China. Brands are developing masks tailored to specific skin concerns, incorporating ingredients like sodium hyaluronate and collagen, while also exploring sustainable, eco-friendly materials. Multifunctional masks that combine benefits like anti-aging, hydration, and brightening are becoming popular among busy consumers seeking effective, convenient solutions.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Dehydroepiandrosterone (DHEA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dehydroepiandrosterone (DHEA).
The Dehydroepiandrosterone (DHEA) market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dehydroepiandrosterone (DHEA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dehydroepiandrosterone (DHEA) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dehydroepiandrosterone (DHEA) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dehydroepiandrosterone (DHEA) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dehydroepiandrosterone (DHEA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Dehydroepiandrosterone (DHEA) Market Overview
1.1 Product Definition
1.2 Dehydroepiandrosterone (DHEA) by Type
1.2.1 Global Dehydroepiandrosterone (DHEA) Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 ≥ 99%
1.2.3 Others
1.3 Dehydroepiandrosterone (DHEA) by Application
1.3.1 Global Dehydroepiandrosterone (DHEA) Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Medicine
1.3.3 Dietary Supplements
1.3.4 Skin Care Products
1.3.5 Reagents
1.3.6 Others
1.4 Global Market Growth Prospects
1.4.1 Global Dehydroepiandrosterone (DHEA) Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Dehydroepiandrosterone (DHEA) Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Dehydroepiandrosterone (DHEA) Production Estimates and Forecasts (2020-2031)
1.4.4 Global Dehydroepiandrosterone (DHEA) Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Dehydroepiandrosterone (DHEA) Production Market Share by Manufacturers (2020-2025)
2.2 Global Dehydroepiandrosterone (DHEA) Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Dehydroepiandrosterone (DHEA), Industry Ranking, 2023 VS 2024
2.4 Global Dehydroepiandrosterone (DHEA) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Dehydroepiandrosterone (DHEA) Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Dehydroepiandrosterone (DHEA), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Dehydroepiandrosterone (DHEA), Product Offered and Application
2.8 Global Key Manufacturers of Dehydroepiandrosterone (DHEA), Date of Enter into This Industry
2.9 Dehydroepiandrosterone (DHEA) Market Competitive Situation and Trends
2.9.1 Dehydroepiandrosterone (DHEA) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Dehydroepiandrosterone (DHEA) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Dehydroepiandrosterone (DHEA) Production by Region
3.1 Global Dehydroepiandrosterone (DHEA) Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Dehydroepiandrosterone (DHEA) Production Value by Region (2020-2031)
3.2.1 Global Dehydroepiandrosterone (DHEA) Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Dehydroepiandrosterone (DHEA) by Region (2026-2031)
3.3 Global Dehydroepiandrosterone (DHEA) Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Dehydroepiandrosterone (DHEA) Production Volume by Region (2020-2031)
3.4.1 Global Dehydroepiandrosterone (DHEA) Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Dehydroepiandrosterone (DHEA) by Region (2026-2031)
3.5 Global Dehydroepiandrosterone (DHEA) Market Price Analysis by Region (2020-2025)
3.6 Global Dehydroepiandrosterone (DHEA) Production and Value, Year-over-Year Growth
3.6.1 North America Dehydroepiandrosterone (DHEA) Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Dehydroepiandrosterone (DHEA) Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Dehydroepiandrosterone (DHEA) Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Dehydroepiandrosterone (DHEA) Production Value Estimates and Forecasts (2020-2031)
4 Dehydroepiandrosterone (DHEA) Consumption by Region
4.1 Global Dehydroepiandrosterone (DHEA) Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Dehydroepiandrosterone (DHEA) Consumption by Region (2020-2031)
4.2.1 Global Dehydroepiandrosterone (DHEA) Consumption by Region (2020-2025)
4.2.2 Global Dehydroepiandrosterone (DHEA) Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Dehydroepiandrosterone (DHEA) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Dehydroepiandrosterone (DHEA) Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Dehydroepiandrosterone (DHEA) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Dehydroepiandrosterone (DHEA) Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Dehydroepiandrosterone (DHEA) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Dehydroepiandrosterone (DHEA) Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Dehydroepiandrosterone (DHEA) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Dehydroepiandrosterone (DHEA) Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Dehydroepiandrosterone (DHEA) Production by Type (2020-2031)
5.1.1 Global Dehydroepiandrosterone (DHEA) Production by Type (2020-2025)
5.1.2 Global Dehydroepiandrosterone (DHEA) Production by Type (2026-2031)
5.1.3 Global Dehydroepiandrosterone (DHEA) Production Market Share by Type (2020-2031)
5.2 Global Dehydroepiandrosterone (DHEA) Production Value by Type (2020-2031)
5.2.1 Global Dehydroepiandrosterone (DHEA) Production Value by Type (2020-2025)
5.2.2 Global Dehydroepiandrosterone (DHEA) Production Value by Type (2026-2031)
5.2.3 Global Dehydroepiandrosterone (DHEA) Production Value Market Share by Type (2020-2031)
5.3 Global Dehydroepiandrosterone (DHEA) Price by Type (2020-2031)
6 Segment by Application
6.1 Global Dehydroepiandrosterone (DHEA) Production by Application (2020-2031)
6.1.1 Global Dehydroepiandrosterone (DHEA) Production by Application (2020-2025)
6.1.2 Global Dehydroepiandrosterone (DHEA) Production by Application (2026-2031)
6.1.3 Global Dehydroepiandrosterone (DHEA) Production Market Share by Application (2020-2031)
6.2 Global Dehydroepiandrosterone (DHEA) Production Value by Application (2020-2031)
6.2.1 Global Dehydroepiandrosterone (DHEA) Production Value by Application (2020-2025)
6.2.2 Global Dehydroepiandrosterone (DHEA) Production Value by Application (2026-2031)
6.2.3 Global Dehydroepiandrosterone (DHEA) Production Value Market Share by Application (2020-2031)
6.3 Global Dehydroepiandrosterone (DHEA) Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Yicheng Goto Pharmaceuticals Co.,Ltd.
7.1.1 Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Company Information
7.1.2 Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Product Portfolio
7.1.3 Yicheng Goto Pharmaceuticals Co.,Ltd. Dehydroepiandrosterone (DHEA) Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Yicheng Goto Pharmaceuticals Co.,Ltd. Main Business and Markets Served
7.1.5 Yicheng Goto Pharmaceuticals Co.,Ltd. Recent Developments/Updates
7.2 Junye Pharmaceutical Co., Ltd.
7.2.1 Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Company Information
7.2.2 Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Product Portfolio
7.2.3 Junye Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Junye Pharmaceutical Co., Ltd. Main Business and Markets Served
7.2.5 Junye Pharmaceutical Co., Ltd. Recent Developments/Updates
7.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd.
7.3.1 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Company Information
7.3.2 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Product Portfolio
7.3.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Main Business and Markets Served
7.3.5 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Recent Developments/Updates
7.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
7.4.1 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Company Information
7.4.2 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Product Portfolio
7.4.3 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Main Business and Markets Served
7.4.5 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
7.5 Jiangsu Jiaerke Pharmaceuticals Group Corp.
7.5.1 Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Company Information
7.5.2 Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Product Portfolio
7.5.3 Jiangsu Jiaerke Pharmaceuticals Group Corp. Dehydroepiandrosterone (DHEA) Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Jiangsu Jiaerke Pharmaceuticals Group Corp. Main Business and Markets Served
7.5.5 Jiangsu Jiaerke Pharmaceuticals Group Corp. Recent Developments/Updates
7.6 Wudang Antai Pharmaceutical Co., Ltd.
7.6.1 Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Company Information
7.6.2 Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Product Portfolio
7.6.3 Wudang Antai Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Wudang Antai Pharmaceutical Co., Ltd. Main Business and Markets Served
7.6.5 Wudang Antai Pharmaceutical Co., Ltd. Recent Developments/Updates
7.7 Shandong Saito Biotechnology Co., Ltd.
7.7.1 Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Company Information
7.7.2 Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Product Portfolio
7.7.3 Shandong Saito Biotechnology Co., Ltd. Dehydroepiandrosterone (DHEA) Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Shandong Saito Biotechnology Co., Ltd. Main Business and Markets Served
7.7.5 Shandong Saito Biotechnology Co., Ltd. Recent Developments/Updates
7.8 Hubei Dan'ao Pharmaceutical Co., Ltd.
7.8.1 Hubei Dan'ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Company Information
7.8.2 Hubei Dan'ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Product Portfolio
7.8.3 Hubei Dan'ao Pharmaceutical Co., Ltd. Dehydroepiandrosterone (DHEA) Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Hubei Dan'ao Pharmaceutical Co., Ltd. Main Business and Markets Served
7.8.5 Hubei Dan'ao Pharmaceutical Co., Ltd. Recent Developments/Updates
7.9 Symbiotec Pharma Lab Pvt. Ltd.
7.9.1 Symbiotec Pharma Lab Pvt. Ltd. Dehydroepiandrosterone (DHEA) Company Information
7.9.2 Symbiotec Pharma Lab Pvt. Ltd. Dehydroepiandrosterone (DHEA) Product Portfolio
7.9.3 Symbiotec Pharma Lab Pvt. Ltd. Dehydroepiandrosterone (DHEA) Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Symbiotec Pharma Lab Pvt. Ltd. Main Business and Markets Served
7.9.5 Symbiotec Pharma Lab Pvt. Ltd. Recent Developments/Updates
7.10 NutriScience Innovations, LLC
7.10.1 NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Company Information
7.10.2 NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Product Portfolio
7.10.3 NutriScience Innovations, LLC Dehydroepiandrosterone (DHEA) Production, Value, Price and Gross Margin (2020-2025)
7.10.4 NutriScience Innovations, LLC Main Business and Markets Served
7.10.5 NutriScience Innovations, LLC Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Dehydroepiandrosterone (DHEA) Industry Chain Analysis
8.2 Dehydroepiandrosterone (DHEA) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Dehydroepiandrosterone (DHEA) Production Mode & Process Analysis
8.4 Dehydroepiandrosterone (DHEA) Sales and Marketing
8.4.1 Dehydroepiandrosterone (DHEA) Sales Channels
8.4.2 Dehydroepiandrosterone (DHEA) Distributors
8.5 Dehydroepiandrosterone (DHEA) Customer Analysis
9 Dehydroepiandrosterone (DHEA) Market Dynamics
9.1 Dehydroepiandrosterone (DHEA) Industry Trends
9.2 Dehydroepiandrosterone (DHEA) Market Drivers
9.3 Dehydroepiandrosterone (DHEA) Market Challenges
9.4 Dehydroepiandrosterone (DHEA) Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Dehydroepiandrosterone (DHEA) market size was US$ 50.97 million in 2025 and is forecast to reach a readjusted size of US$ 81.63 million by 2032 with a CAGR of 7.1% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 78
USD 4250.00
(Single User License)
The global Dehydroepiandrosterone (DHEA) market is projected to grow from US$ 50.97 million in 2025 to US$ 81.63 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 135
USD 4900.00
(Single User License)
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 50.97 million in 2025 and is projected to reach US$ 81.63 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 106
USD 3950.00
(Single User License)
The global Dehydroepiandrosterone (DHEA) market was valued at US$ 50.97 million in 2025 and is anticipated to reach US$ 81.63 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 127
USD 2900.00
(Single User License)
The global Dehydroepiandrosterone (DHEA) market is projected to grow from US$ 49 million in 2024 to US$ 76.7 million by 2031, at a CAGR of 7.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 143
USD 4900.00
(Single User License)
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 49 million in 2024 and is forecast to a readjusted size of US$ 76.7 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-03-26
Pages: 98
USD 3950.00
(Single User License)
Valued at US$ 51 million in 2024, the global Dehydroepiandrosterone (DHEA) market is forecast to reach US$ 76.7 million by 2030, at a CAGR of 7.1% during the forecast period.
Published Date: 2025-03-26
Pages: 149
USD 4900.00
(Single User License)
The global Dehydroepiandrosterone (DHEA) market size was US$ 49 million in 2024 and is forecast to a readjusted size of US$ 76.7 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-03-26
Pages: 79
USD 4250.00
(Single User License)
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 48.9 million in 2024 and is forecast to a readjusted size of US$ 66.8 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 101
USD 3950.00
(Single User License)
Dehydroepiandrosterone is a precursor hormone, which means it has little biological effect on its own, but has powerful effects when converted into other hormones such as testosterone and oestradiol.
Published Date: 2024-04-22
Pages: 86
USD 4900.00
(Single User License)
The global Dehydroepiandrosterone (DHEA) market size was US$ 50.97 million in 2025 and is forecast to reach a readjusted size of US$ 81.63 million by 2032 with a CAGR of 7.1% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 78
The global Dehydroepiandrosterone (DHEA) market is projected to grow from US$ 50.97 million in 2025 to US$ 81.63 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 135
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 50.97 million in 2025 and is projected to reach US$ 81.63 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-03-05
Pages: 106
The global Dehydroepiandrosterone (DHEA) market was valued at US$ 50.97 million in 2025 and is anticipated to reach US$ 81.63 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-03-05
Pages: 127
The global Dehydroepiandrosterone (DHEA) market is projected to grow from US$ 49 million in 2024 to US$ 76.7 million by 2031, at a CAGR of 7.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 143
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 49 million in 2024 and is forecast to a readjusted size of US$ 76.7 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-03-26
Pages: 98
Valued at US$ 51 million in 2024, the global Dehydroepiandrosterone (DHEA) market is forecast to reach US$ 76.7 million by 2030, at a CAGR of 7.1% during the forecast period.
Published: 2025-03-26
Pages: 149
The global Dehydroepiandrosterone (DHEA) market size was US$ 49 million in 2024 and is forecast to a readjusted size of US$ 76.7 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-03-26
Pages: 79
The global market for Dehydroepiandrosterone (DHEA) was estimated to be worth US$ 48.9 million in 2024 and is forecast to a readjusted size of US$ 66.8 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 101
Dehydroepiandrosterone is a precursor hormone, which means it has little biological effect on its own, but has powerful effects when converted into other hormones such as testosterone and oestradiol.
Published: 2024-04-22
Pages: 86
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now